Market Newswire

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 30, 2022, Douglas N. Armer, Executive Vice President, Capital Markets and Treasurer, of Blackstone Mortgage Trust, Inc. (the “Company” or “BXMT”), gave notice of his resignation to the Board of Directors (the “Board”)…

Read More “8-K Emp Changes – BLACKSTONE MORTGAGE TRUST, INC. (0001061630) June 30” »

Item 1.01. Entry into a Material Definitive Agreement. On July 1, 2022, Helix Energy Solutions Group, Inc., (“Helix” or the “Company”), Helix Well Ops Inc., Helix Robotics Solutions, Inc., Deepwater Abandonment Alternatives, Inc., Helix Well Ops (U.K.) Limited and Helix Robotics Solutions Limited (collectively, the “Borrowers”), the guarantors party thereto, the lenders party thereto and…

Read More “8-K Material Agrmt – HELIX ENERGY SOLUTIONS GROUP INC (0000866829) July 01” »

Item 3.02 Unregistered Sales of Equity SecuritiesOn June 30, 2022, Siemens Industry, Inc. (“Siemens Industry”), a wholly owned, indirect subsidiary of Siemens AG, provided a notice of exercise of its redemption right pursuant to the terms of the Third Amended and Restated Limited Liability Company Agreement of Fluence Energy, LLC (the “LLC Agreement”) with respect…

Read More “8-K – Fluence Energy, Inc. (0001868941) June 30” »

Item 3.02 Unregistered Sales of Equity Security.As previously disclosed by MedAvail Holdings, Inc. (the “Company”) in its Current Report on Form 8-K that was filed on April 4, 2022, the Company entered into a Securities Purchase Agreement on March 30, 2022 (the “Purchase Agreement”) with the purchasers set forth on the signature pages thereto (the…

Read More “8-K – MedAvail Holdings, Inc. (0001402479) July 01” »

Item 8.01. Other Events As previously disclosed, on December 30, 2021, Greenlane Holdings, Inc. (the “Company”) entered into a Secured Promissory Note (the “Note”) with Aaron LoCascio, the former President and co-founder of the Company and a member of the Company’s Board of Directors, which provides for a loan of $8.0 million maturing on June…

Read More “8-K Other Events – Greenlane Holdings, Inc. (0001743745) June 30” »

Item 7.01 Regulation FD Disclosure. On July 1, 2022, Intercept Pharmaceuticals, Inc. (“Intercept”) issued a press release announcing the closing of its previously announced transaction with Advanz Pharma. A copy of the press release is attached as Exhibit 99.1 and incorporated by reference. Intercept will follow with a further Current Report on Form 8-K containing…

Read More “8-K Reg FD – INTERCEPT PHARMACEUTICALS, INC. (0001270073) July 01” »